| NCT Number | NCT04668261 |
| Lead Sponsor | University of Zurich |
| Conditions | Brain Blood Flow Impairment |
| Enrollment | 400 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-11-01 (estimated) |
| Study Completion | 2027-11-01 (estimated) |
| Updated on ClinicalTrials.gov | 2020-12-29 |